45 | Levodopa (L Dopa)FDA LinkGeneric
07/2022
-
08/2005 |
29 | Dopamine (Intropin)FDA LinkGeneric
07/2022
-
08/2005 |
10 | Serotonin (5 Hydroxytryptamine)IBA
07/2022
-
03/2003 |
9 | 5-HT1A Serotonin ReceptorIBA
11/2013
-
05/2006 |
7 | Oxidopamine (6 Hydroxydopamine)IBA
01/2021
-
05/2006 |
5 | SK&F 81297IBA
01/2019
-
12/2008 |
3 | Vilazodone HydrochlorideIBA
07/2022
-
11/2018 |
3 | Acetylcholine (Acetylcholine Chloride)FDA Link
01/2021
-
01/2018 |
3 | Cholinergic Agents (Cholinergics)IBA
01/2021
-
01/2018 |
3 | salicylhydroxamic acid (SHAM)IBA
01/2021
-
06/2011 |
3 | Dopamine Receptors (Dopamine Receptor)IBA
01/2020
-
07/2007 |
3 | Glutamic Acid (Glutamate)FDA Link
11/2017
-
06/2011 |
2 | Dopamine D3 ReceptorsIBA
03/2021
-
01/2021 |
2 | Proteins (Proteins, Gene)FDA Link
01/2021
-
11/2016 |
2 | Phosphotransferases (Kinase)IBA
01/2021
-
11/2013 |
2 | gamma-Aminobutyric Acid (GABA)IBA
01/2020
-
01/2016 |
2 | 2,3,4,5- Tetrahydro- 7,8- dihydroxy- 1- phenyl- 1H- 3- benzazepine (SKF 38393)IBA
01/2020
-
01/2017 |
2 | QuinpiroleIBA
01/2019
-
07/2015 |
2 | Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2018
-
07/2013 |
2 | Neurotransmitter Agents (Neurotransmitter)IBA
01/2018
-
01/2016 |
2 | Pharmaceutical PreparationsIBA
09/2017
-
04/2016 |
2 | Immunoglobulin E (IgE)IBA
11/2015
-
05/2014 |
2 | Dopamine D1 Receptors (Dopamine D1 Receptor)IBA
09/2009
-
05/2006 |
2 | hydroxide ionIBA
05/2009
-
12/2008 |
1 | 1- (1- benzyl- 4- hydroxypiperidin- 4- ylmethyl)- 2(1H)- pyridinoneIBA
07/2022 |
1 | VortioxetineIBA
07/2022 |
1 | Amantadine (Aman)FDA LinkGeneric
01/2022 |
1 | Excitatory Amino Acid AntagonistsIBA
01/2022 |
1 | EnzymesIBA
01/2021 |
1 | Protein Kinases (Protein Kinase)IBA
01/2021 |
1 | Biological ProductsIBA
01/2021 |
1 | urotensin IIIBA
01/2021 |
1 | 3,4,4a,10b- tetrahydro- 4- propyl- 2H,5H- (1)benzopyrano(4,3- b)- 1,4- oxazin- 9- olIBA
01/2020 |
1 | TropicamideFDA LinkGeneric
01/2019 |
1 | AutoreceptorsIBA
01/2019 |
1 | Trihexyphenidyl (Artane)FDA LinkGeneric
01/2019 |
1 | Serotonin ReceptorsIBA
11/2018 |
1 | Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA
11/2017 |
1 | Glutamate Receptors (Glutamate Receptor)IBA
11/2017 |
1 | Ceftriaxone (Ceftriaxon)FDA LinkGeneric
11/2017 |
1 | AntioxidantsIBA
09/2017 |
1 | NeurotoxinsIBA
09/2017 |
1 | ropinirole (Requip)FDA LinkGeneric
09/2017 |
1 | 3- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methyl- 6- methylaminopyridin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA
01/2017 |
1 | 3- chloro- 4- fluorophenyl- (4- fluoro- 4- (((5- methylpyrimidin- 2- ylmethyl)amino)methyl)piperidin- 1- yl)methanoneIBA
01/2017 |
1 | vanoxerine (I 893)IBA
11/2016 |
1 | CitalopramFDA LinkGeneric
11/2016 |
1 | nisoxetineIBA
11/2016 |
1 | Naproxen (Naprosyn)FDA LinkGeneric
04/2016 |
1 | Clomipramine (Anafranil)FDA LinkGeneric
03/2016 |
1 | Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
03/2016 |
1 | alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2016 |
1 | AllergensIBA
11/2015 |
1 | Therapeutic UsesIBA
08/2015 |
1 | atipamezoleIBA
08/2015 |
1 | Clonidine (ST 155)FDA LinkGeneric
08/2015 |
1 | beta Adrenergic ReceptorsIBA
07/2015 |
1 | Propranolol (Inderal)FDA LinkGeneric
07/2015 |
1 | Biomarkers (Surrogate Marker)IBA
11/2013 |
1 | Interleukin-1 (Interleukin 1)IBA
07/2013 |
1 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2013 |
1 | Dihydrotachysterol (AT 10)IBA
06/2013 |
1 | Dopamine Agonists (Dopamine Agonist)IBA
06/2013 |
1 | alpha- (4- fluorophenyl)- 4- (5- fluoro- 2- pyrimidinyl)- 1- piperazine butanolIBA
06/2013 |
1 | Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA
05/2013 |
1 | Tuberculin (PPD)IBA
05/2013 |
1 | Messenger RNA (mRNA)IBA
05/2013 |
1 | pre-prodynorphinIBA
05/2013 |
1 | ApomorphineFDA Link
09/2012 |
1 | Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
09/2012 |
1 | Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
09/2012 |
1 | Adrenergic Antagonists (Antiadrenergic Agents)IBA
01/2012 |
1 | Adrenergic Receptors (Adrenergic Receptor)IBA
06/2011 |